-
Mashup Score: 2FACT-HN-RAD Measure for Adverse Effects of Radiation Therapy in Head and Neck Cancer - 7 month(s) ago
This qualitative study develops an 8-item measure for monitoring patient-reported adverse effects related to radiation therapy for head and neck squamous cell carcinoma.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Association Between Antibiotic Prescribing and Time to Diagnosis of Head and Neck Cancer - 8 month(s) ago
This cohort study examines the factors involved and times to diagnosis and treatment initiation in patients with head and neck cancer at the time of presentation with symptoms.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An Original Investigation in @JAMAOto by @AHNSinfo "Association Between Antibiotic Prescribing and Time to Diagnosis of Head and Neck Cancer" Readđź”˝: https://t.co/92vrSFAPng #headandneck #antibiotic #original #investigation #jama #oto
-
-
Mashup Score: 0
This survey study assesses use of American Head and Neck Society Virtual Tumor Board videos as a virtual learning for head and neck surgical oncology trainees.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In @JAMAOto an @AHNSinfo article, "Virtual Tumor Boards for Remote Learning in Head and Neck Surgical Oncology" đź”—: https://t.co/n44Y8rQSzn #Virtual #tumorboard #headandneck #surgical #oncology #educationalgrowth #Science #learning
-
-
Mashup Score: 0ESPO 2023 | Registration - 12 month(s) ago
**ESPO Members please note – you can only access the member fees by using the personalised link we have sent you. Only paid members are eligible for the member fees. If you cannot locate the email, please email espo2023@abbey.ie ​ Registration Fees Early bird fees on or before 20th March 2023: ESPO Members                                       …
Source: ESPO 2023Categories: Latest Headlines, OtolaryngologyTweet-
Arriving to #ESPO2023 via John Lennon Airport? Be sure to look out for the #Yellow Submarine!🚤 ⏰Book now if you haven’t already! https://t.co/3biWIRn9B0 #ENTAuds #otorhinology #otorhinolaryngology #ORL #ENT #headandneck #pediatric #paediatric #PedENT @RosaPinpoint https://t.co/PjLeL0Y6En
-
-
Mashup Score: 0
This cohort study evaluates the association of overall social vulnerability and specific social determinants of health with disparities in head and neck cancer care and prognosis among children and adolescents in the United States.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
For children with #HeadAndNeck cancer, increasing social vulnerabilities are linked with worse disparities in survival length, surveillance period, staging, and treatment. https://t.co/GuS8IQySvN
-
-
Mashup Score: 0
NEJM Catalyst Innovations in Care Delivery, a peer-reviewed journal from NEJM Group, publishes twelve digital issues a year focusing on the latest innovations, big ideas, and practical solutions for health care delivery transformation. Explore the current issue and other information about the journal. …
Source: catalyst.nejm.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In our January issue: #IntegratedPracticeUnit #StrokeCare delivery, #HeadAndNeck cancer clinic, #PalliativeCare practices, #HealthInformation exchange policy, #Readmissions reduction, care for patients with #IDD: https://t.co/1uDnmqwyg0
-
-
Mashup Score: 0
Treating head and neck cancers is a complex process that requires interaction among an unusually large number of specialists and types of care. Emory University has made significant improvements by…
Source: catalyst.nejm.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Treating #HeadAndNeck cancers is a complex process requiring interaction among many specialists. @WinshipAtEmory made significant improvements by treating all patients in a colocated multidisciplinary clinic: https://t.co/5QqVIHustc @trhalle @DrNabilSaba @StokedStokes #oncology
-
-
Mashup Score: 1Combined biomarker analysis shows promise in solid tumours - 1 year(s) ago
Pre-treatment expression of Ki-67 plus FOXC1 plus PD-L1 predicted response to neoadjuvant treatment in breast and head and neck tumours
Source: Daily ReporterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ESMOImmuno22: Pre-treatment expression of Ki-67 plus FOXC1 plus PD-L1 predicted response to neoadjuvant treatment in #Breast and #HeadandNeck tumours, although more work is required to determine its use in the context of immunotherapy alone. 👉https://t.co/7ob0KxfnyA https://t.co/ld9eGZGhER
-
-
Mashup Score: 0
PURPOSE Pembrolizumab and pembrolizumab-chemotherapy demonstrated efficacy in recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048. Post hoc analysis of long-term efficacy and progression-free survival on next-line therapy (PFS2) is presented. METHODS Patients were randomly assigned (1:1:1) to pembrolizumab, pembrolizumab-chemotherapy, or cetuximab-chemotherapy. Efficacy was…
Source: Journal of Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
✅ KEYNOTE-048: First-line pembrolizumab and pembrolizumab-chemotherapy provide highly durable benefits in relapsed/metastatic #HeadAndNeck squamous cell carcinoma 👉 https://t.co/FkBM4zwQnT #JCO #hncsm #immunotherapy https://t.co/mnMNQeGsIe
-
-
Mashup Score: 1
A retrospective analysis suggests carboplatin is better than cetuximab as a radiosensitizing agent.
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet-
When #Cisplatin won’t do, try #Carboplatin in head and neck cancer👇 https://t.co/TWVEyhgWWG @MDedgeHemOnc @jimkling #Headandneck #ENT https://t.co/jAJ3qJcxnh
-
@AHNSinfo #Original #investigation in @JAMAOto, "Monitoring Adverse Effects of Radiation Therapy in Patients With Head and Neck CancerThe FACT-HN-RAD Patient-Reported Outcome Measure" đź”—: https://t.co/I73LkbLBbN #HeadandNeck #CancerResearch #NRG #oncology #iamoto https://t.co/OsRaLu9V4T